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Percutaneous Intervention in Axillary
Loop-Configured Arteriovenous Grafts for
Chronic Hemodialysis Patients
Objective: The purpose of this study was to evaluate the fistulographic fea-
tures of malfunctioning axillary loop-configured arteriovenous grafts and the effi-
cacy of percutaneous interventions in failed axillary loop-configured arteriove-
nous grafts.
Materials and Methods: Ten patients with axillary loop-configured arteriove-
nous grafts were referred for evaluation of graft patency or upper arm swelling.
Fistulography and percutaneous intervention, including thrombolysis, percuta-
neous transluminal angioplasty and stent placement, were performed. Statistical
analysis of the procedure success rate and the primary and secondary patency
rates was done.
Results: Four patients had graft related and subclavian venous stenosis, two
patients had graft related stenosis and another four patients had subclavian
venous stenosis only. Sixteen sessions of interventional procedures were per-
formed in eight patients (average: 2 sessions / patient) until the end of follow-up.
An interventional procedure was not done in two patients with central venous
stenosis. The overall procedure success rate was 69% (11 of 16 sessions). The
post-intervention primary and secondary patency rates were 50% and 63% at
three months, 38% and 63% at six months and 25% and 63% at one year,
respectively.
Conclusion: Dysfunctional axillary loop-configured arteriovenous grafts almost
always had subclavian venous and graft-related stenosis. Interventional treat-
ments are helpful to overcome this and these treatments are expected to play a
major role in restoring and maintaining the axillary loop-configured arteriovenous
loop grafts.
n autogenous arteriovenous fistula (AVF) is clearly the surgical modality
of choice for end-stage renal disease (ESRD) patients on hemodialysis.
Creation of a fistula between the cephalic vein and the radial or brachial
artery is widely regarded as the ideal vascular access. Unfortunately, only a minority
of patients who have ESRD and require vascular access have suitable vessels to create
an autogenous fistula (1). Furthermore, the number of patients who have exhausted
their upper extremity arteriovenous dialysis access sites and who have also lost all
chances for a conventional upper extremity arteriovenous dialysis access has been
increasing, and this is in line with the general increase of the hemodialysis patient
population (2).
In our institute, axillary loop-configured arteriovenous grafts (ALAVGs) were
created in those patients who had lost all opportunities for having upper extremity
arteriovenous dialysis access. We experienced dysfunctional ALAVGs and then we
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Aperformed percutaneous interventions. There are some
surgical reports on this type of exotic arteriovenous graft
(AVG). However, there have been only a few published
studies on the results of interventional procedures in such
grafts (3-5). The purpose of this study was to evaluate the
fistulographic features of ALAVGs and the efficacy of
percutaneous intervention in malfunctioning ALAVGs.
MATERIALS AND METHODS
From March 2003 to February 2005, 10 patients (3
males and 7 females: mean age, 58.7 years [range, 43-76
years]) with ALAVGs were referred to our interventional
radiology practice for evaluation of graft patency or upper
arm swelling. This study was approved by our Institutional
Review Board, and all the patients gave us their informed
written consent. The patients had no central venous
stenosis or obstruction on venography before creation of
the hemodialysis grafts. All patients had lost their optimal
sites for a hemodialysis fistula or graft in both upper
extremities and they had undergone an operation for
creating ALAVGs with a 4-6 mm or 4-7 mm ringed-
tapered polytetrafluoroethylene graft (PTFE, Vascugraft B
BRAUN, Berlin, Germany).
Eight patients were referred for evaluation and treatment
of graft dysfunction or graft failure, which was clinically
suggested on the basis of clot aspiration, decreased or
impalpable thrill, and a decreased flow rate during
hemodialysis. The other two patients had swelling of the
ipsilateral upper arm (Table 1). The interval between the
creation of the ALAVGs and the first intervention was 7 to
1,184 days (average, 272.8 ± 329.1).
Fistulography and the Interventional Procedures
All the interventional procedures were performed with
the patients admitted to the hospital. A duplex ultrasound
examination was done prior to the interventional
procedures. When thrombus was present, 100,000 IU of
urokinase was administrated into the graft, and aspiration
thrombectomy was done 1 or 2 hours later (the ‘lyse and
wait’ technique) (6). The ‘apex puncture technique’ was
used in all cases (7). The apex of the graft was punctured
using a 21 gauge needle, and contrast media was then
slowly injected. An 8 Fr Hoffman sheath (Cook,
Bloomington, IN) was inserted through the apex of the
graft, and manual aspiration was then performed. The
thrombus in the venous limb was aspirated first and, if
present, any thrombus in the arterial limb was then
removed after changing the direction of the sheath into the
arterial limb. Fistulography was repeated after aspiration
thrombectomy by using a 5 Fr multiside-hole or Cobra
Catheters (Cook, Bloomington, IN) to evaluate the precise
location of any stenosis or central venous stenosis, and to
determine the diameters of the graft and vein.
Percutaneous transluminal angioplasty (PTA) was
performed after the stenosis was diagnosed, 6 to 8 mm
PTA balloon dilatation catheters were used for the
intragraft and anastomotic stenoses, and 12-14 mm PTA
balloon dilatation catheters were used for the central
venous stenoses. A 6 to 8 mm cutting balloon catheter
(Boston Scientifics, IN) was applied when necessary to
abolish the waist of a tight stenosis. A small amount of
residual thrombus, if present, was pushed out into the
central veins after dilatation of the stenotic segment.
A stent was applied in the case of elastic recoil after PTA
with using the usual balloon catheter or a cutting balloon
catheter.
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Table 1. Demographic Data and Fistulographic Features in All Cases
Interval 
Size  Stenosis Site
Case between 
of 
Cause of 
No.
Gender Age
Operation and  Fistulography Arterial  Venous  Intragraft Subclavian
First Intervention
ALAVG Anastomosis Anastomosis Vein
01 F 43 235 days 4 - 6 mm Clot aspiration o o
02 M 57 204 days 4 - 6 mm Clot aspiration o o o o
03 F 73 7 days 4 - 6 mm Decreased thrill o
04 F 49 211 days 4 - 6 mm Clot aspiration o
05 F 48 252 days 4 - 6 mm Clot aspiration o o
06 F 67 199 days 4 - 6 mm Decreased blood flow rate o o
07 M 45 1,184 days 4 - 7 mm Decreased blood flow rate o o o o
08 M 76 114 days 4 - 6 mm Upper arm swelling o
09 F 75 225 days 4 - 6 mm Impalpable thrill o o o o
10 F 54 97 days 4 - 6 mm Upper arm swelling o
Note.─ ALAVG = axillary loop-configured arteriovenous graftA duplex sonographic exam was performed first for the
case of upper arm swelling. The basilic vein was punctured
under ultrasonographic guidance and a 6-8 Fr introducing
sheath was inserted. A larger size introducing sheath than
the usual size was preferred due to the PTA. A 5 Fr
multisidehole catheter (Cook, Bloomington, IN) was
introduced into the basilic vein for venography. When a
central vein stenosis was found, a 5 Fr Cobra catheter
(Cook, Bloomington, IN) was advanced into the subclavian
artery via the graft to evaluate the precise location of the
anastomotic sites and the anastomotic stenosis. Dilatation
of the stenotic central vein was then performed.
After the interventional procedures, the puncture sites
were closed with a symmetric purse-string suture arrange-
ment using 4-0 nylon monofilament (Ethicon; Johnson &
Johnson, Somerville, NJ). 
Definitions and the Study Endpoints
Follow-up was ended on June 2006 and a retrospective
review of the patients’ charts was done. The procedural
success rate, the post-intervention primary and secondary
patency rates and the complications were defined according
to ‘reporting standards for percutaneous interventions in
dialysis access’ (8). The procedural success rate was defined
as an anatomic success with at least one indicator of either
hemodynamic or clinical success. Primary patency was
defined as the interval following intervention until the next
access thrombosis or repeated intervention. Secondary
patency meant the interval after intervention until the
access was surgically declotted, revised or abandoned
because of the inability to treat the original lesion, the
choice of the surgeon, transplant, the patient was lost to
follow-up etc. Death of a patient was regarded as a
censored case. The 6 month and 12 month post-interven-
tion primary and secondary patency rates were calculated
by the Kaplan-Meier Method using the SPSS for Windows,
version 12.0 (SPSS Inc, Chicago, IL).
Major complications were defined as those resulting in
admission to a hospital for therapy, an unplanned increase
in the level of care, prolonged hospitalization, permanent
adverse sequela or death.
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Fig. 1. 43-year-old female patient (case no. 1) was referred for evaluation of graft patency due to clot aspiration. Initial fistulogram
showed stenosis at arterial and venous anastomoses (A). Percutaneous transluminal angioplasty was performed with 7 mm x 4 cm
sized balloon catheter (B, C). Final fistulogram showed improvement of stenoses and no flow disturbance (D). Hemodialysis has been
performed with this axillary to axillary autogenous arteriovenous fistula graft for 262 days after percutaneous intervention.
CDRESULTS
Fistulographic Features
In all the patients, the outflow vein was the infraclavicu-
lar proximal axillary vein, and the inflow artery was
proximal axillary artery just beneath the infraclavicular
proximal axillary vein. All the arterial and venous anasto-
moses were located near the pinch-off region and they
overlapped each other (Fig. 1). 
On the initial fistulographies, six patients (60%) had
graft-related stenosis; the stenosis was at the arterial
anastomosis in all six patients (100%), the stenosis was at
the venous anastomosis in four (67%), the stenosis was at
both the arterial and venous anastomosis in four (67%)
and there was an intragraft stenosis in four patients (Table
1). Of the six patients with a graft-related stenosis, four
patients also had a subclavian or proximal axillary vein
stenosis. The other four patients showed subclavian or
proximal axillary vein stenosis without a graft-related
stenosis, so there was a total of eight patients who showed
subclavian or proximal axillary vein stenoses. Of these
eight patients, only four patients (50%) had difficult
hemodialysis or hemodialysis failure and they showed
graft-related stenoses; both arterial and venous anasto-
motic stenosis were found in three patients (3 of 4 patients,
75%), and arterial anastomotic stenosis was found in one
patient. The other four patients had neither hemodialysis
failure nor graft-related stenosis on their fistulograms. Two
patients complained of ipsilateral arm swelling that necessi-
tated an interventional procedure. The other two patients
were referred for clot aspiration or decreased thrill;
nevertheless, they did not have difficult hemodialysis or
hemodialysis failure. No further intervention was needed. 
Interventional Procedures
Sixteen sessions of interventional procedures were
performed in eight patients (an average of 2 sessions/
patient) until the end of follow-up, and six patients experi-
enced two or more interventional procedures: there were
eight sessions of PTA with thrombolysis, five sessions of
PTA only and three sessions of stent placement (Figs. 2, 3).
In one female patient, 6 mm × 4 cm and 6 mm × 8 cm
sized Zilver vascular stents (Cook, Bloomington, IN) were
placed for relieving a residual stenosis at a venous anasto-
mosis, but complete failure of the graft occurred. She was
obese and had big breasts. The AVG was movable in
Park et al.
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Fig. 2. 54-year-old female patient (case no. 10) was referred for evaluation of upper arm swelling. Venography and fistulography showed
stenosis in subclavian vein with multiple collateral veins and normal fistulogram (A). After conventional balloon angioplasty, waist of
stenosis did not disappear. We used 8 mm × 2 cm sized cutting balloon (B) and we performed repeated percutaneous transluminal
angioplasty with 14 mm × 4 cm balloon catheter. Waist then disappeared (C). Immediate elastic recoil was found on post-procedural
venography (D). Three days after percutaneous transluminal angioplasty, 14 mm by 6 cm sized Hercules stent was placed (E), and
venogram showed no flow disturbance in arteriovenous graft and subclavian vein.
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Fig. 3. 67-year-old female patient (case no. 6) visited our interventional radiology practice for evaluation of graft dysfunction. Initial fistulo-
gram showed thrombus in graft, and ‘lyse and wait’ technique was performed. Residual thrombus and stenosis at venous arm of graft
were noted on repeated fistulogram (A). Aspiration thrombectomy and percutaneous transluminal angioplasty were done, but elastic
recoil occurred (B). On next day, thrombosis relapsed (C) and 6 mm by 4 cm Zilver stent was placed in stenotic venous arm after
removal of thrombus (D). Eleven days after stent placement, repeated thrombosis was noted on fistulogram, and graft was bent at distal
end of stent (E). Additional 8 mm by 4 cm Zilver stent was placed distally (F). After 21 days, patient was referred for graft dysfunction.
Fistulogram with position change (G, H) showed kinking of venous anastomosis of graft in standing position. Graft moved downward in
standing position, and proximal end of stent folded graft up (arrow). Patient refused additional interventions and tunneled hemodialysis
catheter was placed through right internal jugular vein.
GHaccordance with standing and lying down, and also accord-
ing to movement of the shoulder joint. So the cephalic vein
was folded at the point of the proximal end of the stent
and the graft was completely occluded. In one case of
subclavian venous stenosis, a 14 mm × 6 cm self-expand-
able Hercules stent (S&G Biotech, Seoul, Korea) was
placed because of recoiling phenomenon after PTA. Only
fistulography was done in the other two patients. The
overall procedure success rate was 69% (11 of 16
sessions). Among the eight patients with subclavian venous
stenosis, only four patients with simultaneous graft-related
stenosis had problems during hemodialysis. On the other
hand, the other four patients without simultaneous graft-
related stenosis did well; nevertheless, their subclavian
veins were stenotic. Among all six patients with graft-
related stenosis, four patients showed subclavian venous
stenosis and so balloon angioplasties were done. However,
hemodialysis failure or difficult hemodialysis did not occur,
even though the residual stenosis of the subclavian vein
was over 30% in diameter after PTA.
Follow-up was possible in nine patients with an average
follow-up period of 415.5 days (range: 1 - 700 days). Six
ALAVGs were functioning at the end of follow-up and
three ALAVGs were terminated. In the case of termination
of the ALAVG, tunneled hemodialysis catheters were
inserted for hemodialysis access. One patient died two
weeks after fistulography due to acute myocardial infarc-
tion (Table 2).
The post-intervention patency rates are detailed in
Figure 4. The post-intervention primary and secondary
patency rates of our study were 50% and 63% at three
months, 38% and 63% at six months and 25% and 63%
at one year, respectively.
No major complications occurred. In one patient, distal
arterial embolization occurred at the bifurcation level of
the brachial artery, and this was successfully treated with
thrombolysis and aspiration of the residual embolus. Yet
hospitalization was not prolonged in spite of thrombolysis
therapy and no other complication was noted.
DISCUSSION
When all the upper extremity sites for creating an arteri-
ovenous fistula in a chronic hemodialysis patient are
exhausted, the secondary site that’s most frequently
Park et al.
200 Korean J Radiol 11(2), Mar/Apr 2010
Table 2. Types and Results of Percutaneous Intervention in Each of Cases
Case No. Number of Procedures Type of Procedures
Size of 
Size of Stent
Status at 
Balloon Catheter End of Follow-up
01 1 PTA 06 mm × 4 cm Functioning
08 mm × 4 cm
02 1 PTA with thrombolysis 07 mm × 4 cm Functioning
03 0 Observation Death
04 0 Observation Functioning
05 4 PTA 06 mm × 4 cm Functioning
12 mm × 4 cm
06 3 PTA with thrombolysis, 06 mm × 4 cm 6 mm × 4 cm Terminated
Stent placement 6 mm × 2 cm (CB*) 6 mm × 8 cm
07 2 PTA with thrombolysis 07 mm × 4 cm Terminated
12 mm × 4 cm
08 1 PTA 12 mm × 4 cm Functioning
09 2 PTA with thrombolysis 07 mm × 4 cm Terminated
12 mm × 4 cm
10 2 PTA  8 mm × 2 cm (CB*) 14 mm × 6 cm Functioning
Stent placement 14 mm × 4 cm
Note.─ PTA = percutaneous transluminal angioplasty, CB* = cutting balloon catheter
Fig. 4. Post-intervention cumulative primary and secondary
patency rates.
Primary Patency Rate
Secondary Patency Rate
62.5 62.5 62.5 62.5
50.0
0
0
20
60
40
80
% 100
3 6 9 12
months
37.5
25.0 25.0selected is the leg or permanent venous catheters are used.
However, the femoral vessels are frequently diseased and
the femoral AVG has a high rate of complications such as
infection (20%), thrombosis, extremity loss (22%) and
even a high mortality rate (20%) (9, 10). Permanent
central venous catheters also show a high rate of septic
complications, low patency rates and discomfort (11). The
use of the axillary artery and vein as dialysis access sites is
not a new idea, and various types of AVGs in the anterior
chest wall have been described in the literature since
Manning et al. (12) first reported on an experimental case
in 1975 (2, 12-16). However, an ipsilateral ALAVG is not
popular at present. Hazinedaroglu et al. (2) described only
three cases of ipsilateral ALAVGs among 27 AVGs in the
anterior chest wall, and Jean-Baptiste et al. (3) reported
the midterm results of 27 cases of ipsilateral ALAVG and
they suggested that ALAVG construction may be prefer-
able to lower extremity vascular access. Although we had
not reviewed all the cases of ALAVGs in our institute, the
results of our study also suggest that construction of an
ALAVG may be preferable to lower extremity arteriove-
nous hemodialysis access.
In a large series of AVG stenoses, Maya et al. (17) found
that venous anastomosis was the most common site of
stenosis in an AVG, followed by stenoses of the venous
outlet, intragraft stenoses, central vein stenoses and arterial
anastomosis stenoses. In our present study, the distal
subclavian or proximal axillary vein adjacent to the venous
anastomosis was the most common site of stenosis, while
arterial anastomotic stenosis was the second most common,
followed by venous anastomotic and intragraft stenoses.
Jean-Baptiste et al. (3) reported two cases of stenosis in the
postanastomotic outflow vein with ipsilateral axillary loop
grafts. In most cases of AVG, a subclavian vein stenosis is a
consequence of previous subclavian catheterizations or
high flow from an arteriovenous fistula (18). Yet in our
series, no one had a history of ipsilateral subclavian vein
catheterization or central vein stenosis on the preoperative
venography. The reason for these differences is not
presently clear. However, one possible reason could be the
consequences of the surgical procedures. The anastomotic
sites are very close to the pinch-off region and they are
under the pectoralis major muscle. The space for anasto-
moses is narrow and surrounded by bone and muscle,
which is in contrast to the conventional AVG in the upper
extremity. Furthermore, the arterial and venous anasto-
moses overlap each other in that narrow space, and it is
mandatory to dissect the pectoralis major muscle to expose
the vessels and anastomose the graft to the vessels.
Therefore, formation of granulation tissue and fibrosis is
expected to be more abundant and to have a more severe
affect than that in a conventional AVG. As a consequence,
stenoses of the subclavian and axillary veins and arterial
anastomosis might occur more frequently. High-velocity,
turbulent flow from the nearby graft might also affect the
formation of intimal hyperplasia (18, 19).
For a PTFE AVG to function properly, there must be an
adequate venous outflow, and stenosis of the venous
outflow may cause dysfunction of a PTFE AVG. In the
present study, a stenosis at the central vein, just proximal
to the venous anastomosis, showed a suboptimal post-
interventional result. These lesions might be more fibrous
and have a greater chance of demonstrating elastic recoil
than an intragraft or graft-related stenosis. Yet clinically,
hemodialysis was performed without decreased flow or
increased venous pressure. Although a 50% degree of
narrowing or more was noted in a stenotic subclavian vein,
the subclavian vein is a large vessel and it usually has
abundant collaterals. Therefore, optimal flow for
hemodialysis may be sustained. In the present study, only
one patient needed stent placement in the subclavian vein
due to elastic recoil after PTA and hemodialysis distur-
bance. Levit et al. (20) concluded that PTA of an asympto-
matic central venous stenosis greater than 50% in the
setting of hemodialysis access maintenance procedures is
associated with more rapid progression of stenosis and
escalation of lesions, as compared with a nontreatment
approach, and Kanterman et al. (21) also reported that
central vein stenosis rarely compromises the hemodialysis
access function and that treatment with PTA may not be a
necessary intervention. However, flow disturbance in the
venous outflow tract and repeated thrombosis may occur
due to changes of a patient’s condition. This was the reason
why we performed interventional procedures more
frequently than that reported in the literature. Vijay et al.
(22) reported that 1.22 interventions per graft year are
necessary for maintaining access patency in the natural
history of PTFE grafts. We performed an average of two
interventions per patient.
Elastic recoil after conventional balloon angioplasty is
not uncommon in a stenosis at a venous anastomosis, and
stent placement in a rigid stenosis is an effective procedure
(23-26). We performed two sessions of stent placement at
a stenosis of the venous anastomosis in one female patient.
However, the graft completely failed by kinking of the
cephalic vein, which was due to the gravitational
movement of the patient’s breast. Another case of stent
placement was performed in a subclavian vein stenosis and
this showed good patency during the follow-up.
The post-intervention primary and secondary patency
rates of our study were 50% and 63% at three months,
38% and 63% at six months and 25% and 63% at one
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months in our study was better than the minimum require-
ment recommended by the National Kidney Foundation
(40% primary patency at three months after percutaneous
thrombectomy). On the other hand, the primary and
secondary patency rates at six months and one year were
not so excellent. It is quite possible that these results might
be due to the location of the graft near the pinch-off region
as well as the configuration of the arterial and venous
anastomoses overlapping each other.
The limitations of our study are the small sample size
and the relatively lower primary and secondary patency
rates at six month and one year than the results of percuta-
neous intervention in the usual AVG in the upper extrem-
ity. Other reports that have focused on an AVG in the
anterior chest wall (4, 5) showed that percutaneous
intervention was performed in three and five cases and this
was successful in 66% (2 of 3) and 80% (4 of 5). But no
available data about the primary and secondary patency
rates after percutaneous intervention was noted. Further
experiences with percutaneous intervention in failed
ALAVGs will be needed in a larger population.
Despite of the small sample size, our study showed that
an ALAVG is an alternative for patients who lost an
opportunity for creating an autologous fistula and graft in
their forearm and upper arm. Furthermore, percutaneous
interventional treatments would be helpful for restoring
and maintaining an ALAVG. 
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